{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T20:28:35Z","timestamp":1784147315679,"version":"3.55.0"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"1","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Res Notes"],"published-print":{"date-parts":[[2014,12]]},"DOI":"10.1186\/1756-0500-7-579","type":"journal-article","created":{"date-parts":[[2014,8,29]],"date-time":"2014-08-29T01:01:44Z","timestamp":1409274104000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Patients with Type 2 Diabetes Mellitus failing on oral agents and starting once daily insulin regimen; a small randomized study investigating effects of adding vildagliptin"],"prefix":"10.1186","volume":"7","author":[{"given":"Wendela Lucia","family":"de Ranitz-Greven","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joline Wilhelma Johanna","family":"Beulens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lette Birgit Elisabeth Anne","family":"Hoeks","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerdien","family":"Belle-van Meerkerk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Douwe Hedde","family":"Biesma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harold Wessel","family":"de Valk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2014,8,29]]},"reference":[{"key":"3112_CR1","doi-asserted-by":"publisher","first-page":"1249","DOI":"10.2337\/diab.44.11.1249","volume":"44","author":"U.K. Prospective Diabetes Study Group","year":"1995","unstructured":"U.K. Prospective Diabetes Study Group: U.K. prospective diabetes study 16. Overview of 6 years' therapy of type II diabetes: a progressive disease. Diabetes. 1995, 44: 1249-1258.","journal-title":"Diabetes"},{"key":"3112_CR2","doi-asserted-by":"publisher","first-page":"193","DOI":"10.2337\/dc08-9025","volume":"32","author":"DM Nathan","year":"2009","unstructured":"Nathan DM, Buse JB, Davidson MB, Ferrannini E, Holman RR, Sherwin R, Zinman B: Medical management of hyperglycemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy: a consensus statement of the American Diabetes Association and the European Association for the Study of Diabetes. Diabetes Care. 2009, 32: 193-203.","journal-title":"Diabetes Care"},{"key":"3112_CR3","doi-asserted-by":"publisher","first-page":"1236","DOI":"10.1210\/jc.2008-2152","volume":"94","author":"B Ahren","year":"2009","unstructured":"Ahren B, Schweizer A, Dejager S, Dunning BE, Nilsson PM, Persson M, Foley JE: Vildagliptin enhances islet responsiveness to both hyper- and hypoglycemia in patients with type 2 diabetes. J Clin Endocrinol Metab. 2009, 94: 1236-1243.","journal-title":"J Clin Endocrinol Metab"},{"key":"3112_CR4","doi-asserted-by":"publisher","first-page":"1148","DOI":"10.1007\/s00125-007-0633-0","volume":"50","author":"V Fonseca","year":"2007","unstructured":"Fonseca V, Schweizer A, Albrecht D, Baron MA, Chang I, Dejager S: Addition of vildagliptin to insulin improves glycaemic control in type 2 diabetes. Diabetologia. 2007, 50: 1148-1155.","journal-title":"Diabetologia"},{"key":"3112_CR5","doi-asserted-by":"publisher","first-page":"1509","DOI":"10.2337\/dc09-2191","volume":"33","author":"S Arnolds","year":"2010","unstructured":"Arnolds S, Dellweg S, Clair J, Dain MP, Nauck MA, Rave K, Kapitza C: Further improvement in postprandial glucose control with addition of exenatide or sitagliptin to combination therapy with insulin glargine and metformin: a proof-of-concept study. Diabetes Care. 2010, 33: 1509-1515.","journal-title":"Diabetes Care"},{"key":"3112_CR6","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1185\/03007995.2012.665046","volume":"28","author":"AH Barnett","year":"2012","unstructured":"Barnett AH, Charbonnel B, Donovan M, Fleming D, Chen R: Effect of saxagliptin as add-on therapy in patients with poorly controlled type 2 diabetes on insulin alone or insulin combined with metformin. Curr Med Res Opin. 2012, 28: 513-523.","journal-title":"Curr Med Res Opin"},{"key":"3112_CR7","doi-asserted-by":"publisher","first-page":"93","DOI":"10.3810\/hp.2013.04.1059","volume":"41","author":"B Charbonnel","year":"2013","unstructured":"Charbonnel B, Schweizer A, Dejager S: Combination therapy with DPP-4 inhibitors and insulin in patients with type 2 diabetes mellitus: what is the evidence?. Hosp Pract (1995). 2013, 41: 93-107.","journal-title":"Hosp Pract (1995)"},{"key":"3112_CR8","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1055\/s-2008-1058090","volume":"40","author":"V Fonseca","year":"2008","unstructured":"Fonseca V, Baron M, Shao Q, Dejager S: Sustained efficacy and reduced hypoglycemia during one year of treatment with vildagliptin added to insulin in patients with type 2 diabetes mellitus. Horm Metab Res. 2008, 40: 427-430.","journal-title":"Horm Metab Res"},{"key":"3112_CR9","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1111\/j.1463-1326.2012.01600.x","volume":"14","author":"ES Hong","year":"2012","unstructured":"Hong ES, Khang AR, Yoon JW, Kang SM, Choi SH, Park KS, Jang HC, Shin H, Walford GA, Lim S: Comparison between sitagliptin as add-on therapy to insulin and insulin dose-increase therapy in uncontrolled Korean type 2 diabetes: CSI study. Diabetes Obes Metab. 2012, 14: 795-802.","journal-title":"Diabetes Obes Metab"},{"issue":"3","key":"3112_CR10","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1111\/dom.12020","volume":"15","author":"W Kothny","year":"2013","unstructured":"Kothny W, Foley J, Kozlovski P, Shao Q, Gallwitz B, Lukashevich V: Improved glycaemic control with vildagliptin added to insulin, with or without metformin, in patients with type 2 diabetes mellitus. Diabetes Obes Metab. 2013, 15 (3): 252-257.","journal-title":"Diabetes Obes Metab"},{"key":"3112_CR11","doi-asserted-by":"publisher","first-page":"21","DOI":"10.2147\/VHRM.S39300","volume":"9","author":"V Lukashevich","year":"2013","unstructured":"Lukashevich V, Schweizer A, Foley JE, Dickinson S, Groop PH, Kothny W: Efficacy of vildagliptin in combination with insulin in patients with type 2 diabetes and severe renal impairment. Vasc Health Risk Manag. 2013, 9: 21-28.","journal-title":"Vasc Health Risk Manag"},{"key":"3112_CR12","doi-asserted-by":"publisher","first-page":"1145","DOI":"10.1111\/j.1463-1326.2009.01124.x","volume":"11","author":"J Rosenstock","year":"2009","unstructured":"Rosenstock J, Rendell MS, Gross JL, Fleck PR, Wilson CA, Mekki Q: Alogliptin added to insulin therapy in patients with type 2 diabetes reduces HbA(1C) without causing weight gain or increased hypoglycaemia. Diabetes Obes Metab. 2009, 11: 1145-1152.","journal-title":"Diabetes Obes Metab"},{"key":"3112_CR13","doi-asserted-by":"publisher","first-page":"57","DOI":"10.2147\/VHRM.S40972","volume":"9","author":"A Schweizer","year":"2013","unstructured":"Schweizer A, Foley JE, Kothny W, Ahren B: Clinical evidence and mechanistic basis for vildagliptin's effect in combination with insulin. Vasc Health Risk Manag. 2013, 9: 57-64.","journal-title":"Vasc Health Risk Manag"},{"key":"3112_CR14","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1111\/j.1463-1326.2009.01173.x","volume":"12","author":"T Vilsboll","year":"2010","unstructured":"Vilsboll T, Rosenstock J, Yki-Jarvinen H, Cefalu WT, Chen Y, Luo E, Musser B, Andryuk PJ, Ling Y, Kaufman KD, Amatruda JM, Engel SS, Katz L: Efficacy and safety of sitagliptin when added to insulin therapy in patients with type 2 diabetes. Diabetes Obes Metab. 2010, 12: 167-177.","journal-title":"Diabetes Obes Metab"},{"key":"3112_CR15","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/j.1463-1326.2011.01469.x","volume":"14","author":"CJ Currie","year":"2012","unstructured":"Currie CJ, Johnson JA: The safety profile of exogenous insulin in people with type 2 diabetes: justification for concern. Diabetes Obes Metab. 2012, 14: 1-4.","journal-title":"Diabetes Obes Metab"},{"key":"3112_CR16","doi-asserted-by":"publisher","first-page":"1577","DOI":"10.1007\/s00125-012-2534-0","volume":"55","author":"SE Inzucchi","year":"2012","unstructured":"Inzucchi SE, Bergenstal RM, Buse JB, Diamant M, Ferrannini E, Nauck M, Peters AL, Tsapas A, Wender R, Matthews DR, American Diabetes Association (ADA): Management of hyperglycaemia in type 2 diabetes: a patient-centered approach. Position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD). Diabetologia. 2012, 55: 1577-1596.","journal-title":"Diabetologia"},{"key":"3112_CR17","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1089\/dia.2012.0214","volume":"15","author":"Y Mori","year":"2013","unstructured":"Mori Y, Taniguchi Y, Miyazaki S, Yokoyama J, Utsunomiya K: Effects of add-on treatment with sitagliptin on narrowing the range of glucose fluctuations in Japanese type 2 diabetes patients receiving insulin therapy. Diabetes Technol Ther. 2013, 15: 237-240.","journal-title":"Diabetes Technol Ther"},{"issue":"10","key":"3112_CR18","doi-asserted-by":"publisher","first-page":"1207","DOI":"10.1507\/endocrj.EJ13-0198","volume":"60","author":"S Shimoda","year":"2013","unstructured":"Shimoda S, Iwashita S, Ichimori S, Matsuo Y, Goto R, Maeda T, Matsuo T, Sekigami T, Kawashima J, Kondo T, Matsumura T, Motoshima H, Furukawa N, Nishida K, Araki E: Efficacy and safety of sitagliptin as add-on therapy on glycemic control and blood glucose fluctuation in Japanese type 2 diabetes subjects ongoing with multiple daily insulin injections therapy. Endocr J. 2013, 60 (10): 1207-1214.","journal-title":"Endocr J"},{"issue":"7","key":"3112_CR19","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1111\/dom.12050","volume":"15","author":"RE Van Genugten","year":"2013","unstructured":"Van Genugten RE, Moller-Goede DL, Van Raalte DH, Diamant M: Extra-Pancreatic Effects of Incretin-Based Therapies: Potential Benefit for Cardiovascular Risk Management in Type 2 Diabetes. Diabetes Obes Metab. 2013, 15 (7): 593-606.","journal-title":"Diabetes Obes Metab"},{"key":"3112_CR20","doi-asserted-by":"publisher","first-page":"1282","DOI":"10.2337\/diacare.28.6.1282","volume":"28","author":"M Davies","year":"2005","unstructured":"Davies M, Storms F, Shutler S, Bianchi-Biscay M, Gomis R: Improvement of glycemic control in subjects with poorly controlled type 2 diabetes: comparison of two treatment algorithms using insulin glargine. Diabetes Care. 2005, 28: 1282-1288.","journal-title":"Diabetes Care"},{"key":"3112_CR21","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1089\/dia.2010.0044","volume":"12","author":"WL Greven","year":"2010","unstructured":"Greven WL, Beulens JW, Biesma DH, Faiz S, De Valk HW: Glycemic variability in inadequately controlled type 1 diabetes and type 2 diabetes on intensive insulin therapy: a cross-sectional, observational study. Diabetes Technol Ther. 2010, 12: 695-699.","journal-title":"Diabetes Technol Ther"},{"key":"3112_CR22","doi-asserted-by":"publisher","first-page":"1324","DOI":"10.1007\/s00125-004-1451-2","volume":"47","author":"R Meerwaldt","year":"2004","unstructured":"Meerwaldt R, Graaff R, Oomen PH, Links TP, Jager JJ, Alderson NL, Thorpe SR, Baynes JW, Gans RO, Smit AJ: Simple non-invasive assessment of advanced glycation endproduct accumulation. Diabetologia. 2004, 47: 1324-1330.","journal-title":"Diabetologia"},{"key":"3112_CR23","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1196\/annals.1333.036","volume":"1043","author":"R Meerwaldt","year":"2005","unstructured":"Meerwaldt R, Links T, Graaff R, Thorpe SR, Baynes JW, Hartog J, Gans R, Smit A: Simple noninvasive measurement of skin autofluorescence. Ann N Y Acad Sci. 2005, 1043: 290-298.","journal-title":"Ann N Y Acad Sci"},{"key":"3112_CR24","doi-asserted-by":"publisher","first-page":"531","DOI":"10.7326\/0003-4819-149-8-200810210-00005","volume":"149","author":"K Esposito","year":"2008","unstructured":"Esposito K, Ciotola M, Maiorino MI, Gualdiero R, Schisano B, Ceriello A, Beneduce F, Feola G, Giugliano D: Addition of neutral protamine lispro insulin or insulin glargine to oral type 2 diabetes regimens for patients with suboptimal glycemic control: a randomized trial. Ann Intern Med. 2008, 149: 531-539.","journal-title":"Ann Intern Med"},{"key":"3112_CR25","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1001\/archinternmed.2009.20","volume":"169","author":"A Kooy","year":"2009","unstructured":"Kooy A, De JJ, Lehert P, Bets D, Wulffele MG, Donker AJ, Stehouwer CD: Long-term effects of metformin on metabolism and microvascular and macrovascular disease in patients with type 2 diabetes mellitus. Arch Intern Med. 2009, 169: 616-625.","journal-title":"Arch Intern Med"}],"container-title":["BMC Research Notes"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1756-0500-7-579.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,1,23]],"date-time":"2019-01-23T03:36:01Z","timestamp":1548214561000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcresnotes.biomedcentral.com\/articles\/10.1186\/1756-0500-7-579"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,8,29]]},"references-count":25,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014,12]]}},"alternative-id":["3112"],"URL":"https:\/\/doi.org\/10.1186\/1756-0500-7-579","relation":{},"ISSN":["1756-0500"],"issn-type":[{"value":"1756-0500","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,8,29]]},"assertion":[{"value":"1 April 2014","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 August 2014","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 August 2014","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"579"}}